ClearPoint Neuro, Inc.
NASDAQClearPoint Neuro heads into the post-earnings session carrying a 46% one-month price rally, a heavily rebuilt short position, and a fresh Q1 result that landed on both sides of the line — sales above consensus, losses wider than expected. Short interest is the dominant tension right now. It has climbed to 17.4% of the free float — up 6.7% in a single week and 16.6% over the past…
Snapshot as of 14 May 2026
ClearPoint Neuro heads into the post-earnings session carrying a 46% one-month price rally, a heavily rebuilt short position, and a fresh Q1 result that landed on both sides of the line — sales above consensus, losses…
ClearPoint Neuro heads into tomorrow's earnings report carrying one of the most charged short-selling setups in the health care equipment space. Short sellers are deeply committed here — and haven't flinched despite a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLPT — free to start on ORTEX.
Sign up for free →Open CLPT on ORTEX